We demonstrate that Borrelia burgdorferi infection in the rhesus monkey mimics the early and early disseminated phases of human Lyme disease. Clinical, bacteriological, immunological, and pathological signs of infection were investigated during 13 weeks after inoculation of the spirochete. Three animals were given B.
Lyme borreliosis, caused by the spirochete Borrelia burgdorferi, is considered the most frequently reported arthropod-borne infection in Europe and North America (20) . In fact, in 1992 it accounted for over 80% of all reported vector-borne infections in the United States (10) . The infection, which is transmitted through the bite of ticks of the Ixodes ricinus "complex," has an incidence as high as 100 cases per 100,000 population in hyperendemic foci of the United States (8, 25) .
The disease was first identified in November 1975 in association with an arthropathy afflicting a group of children in the town of Old Lyme, Conn. (39) . Since then, considerable progress has been made in understanding its complexity; Lyme borreliosis is now recognized as a multiple-system disease often heralded by an expanding, usually erythematous, skin lesion. Erythema migrans (EM), as the lesion is called, may be followed by one or more of a variety of neurologic, musculoskeletal, ocular, reticuloendothelial, and cardiac symptoms (39) .
Unfortunately, none of the animal models used currently in the experimental analysis of Lyme disease displays this spectrum of signs. Studies with rabbits (6) , hamsters (13, 19, 21, 36) , rats (3) , mice (4, 34) , and dogs (28) the presence of rhesus monkey complement was also assessed. In every facet of this investigation an attempt was made to identify both similarities and differences between manifestations of infection in the rhesus monkey and in humans.
MATERIALS AND METHODS
Study population. The study population consisted of 12 male, 2-year-old Chinese rhesus monkeys (Macaca mulatta). The average weight of the animals was 3.2 kg (range, 2.6 to 4.0 kg). Three monkeys (group I) were given B.
burgdorfen (strain JD1) (31) by needle inoculations. Six animals (group II) were exposed to the bite of B. burgdorferi (strain JD1)-infected nymphal stage Ixodes dammini ticks.
One animal was given a sham needle inoculation (group I control), and two animals were exposed to the bites of uninfected ticks (group II control).
Animal housing and care. All infected animals were housed in separate quarters within an infectious disease housing area. Control uninfected monkeys were likewise housed by themselves in a separate room. The perimeters of all room entrance and escape routes were taped with Tangle Trap to prevent egress of potentially escaped ticks and access of other possible vectors from the outside. All monkeys were singly caged, were fed commercial monkey chow (Purina Mills 5037), and had water available ad libitum. Animal care facilities were accredited by the American Association for Accreditation of Laboratory Animal Care and licensed by the U.S. Department of Agriculture. All animals were cared for according to the guidelines prescribed by the National Institutes of Health Guide to Laboratory Animal Care.
Inoculation protocol. Animals were separated into two groups according to route of infection. Three animals (group I: animals K167, J743, and J748) were given an inoculation of 4 x 10' B. burgdorferi (strain JD1, third passage) organisms in 3.1 ml of RPMI 1640 medium, using needle and syringe. The inoculum was divided and delivered intraperitoneally (2 ml), subcutaneously (1 ml), and intradermally (0.1 ml) at one site located on the lower right abdominal quadrant. Animal J743 from this group was only given intraperitoneal (3 ml) and intradermal (0.1 ml) inoculations (4 x 108 B. burgdorfen organisms). The control animal for group I, K204, was given a sham inoculation in the same fashion as the infected animals with RPMI 1640 medium alone. Six animals (group II: animals K205, J677, J200, J797, J415, and J307) were infected by bites of B. burgdorferi-infected I. dammini nymphal ticks placed in capsules located dorsolaterally on the cranial thorax (see "Monkey inoculation by ticks" below). Two animals, J622 and J206, were exposed to the bites of uninfected ticks and served as controls for group II.
Animal monitoring: sample collections and physical examinations. Sample collections and physical examinations were performed while the animals were anesthetized with Ketamine HCl (10 mg/kg). Skin biopsies were taken aseptically from the periphery of the inoculation sites, or wherever a lesion arose, with 8-mm dermal biopsy punches after surgical preparation of the skin sites. CSF was taken by cisterna magna puncture after surgical preparation of the overlying skin. Urine was recovered by cystocentesis. Physical examination consisted of visual observation of body systems, auscultation of the thorax, abdominal palpation, and palpation and grading of peripheral lymph nodes and spleen. Electrocardiograms were performed if an abnormal rhythm was noted on auscultation.
Ocular examinations were performed weekly for the first 8 weeks, biweekly for the next 4 weeks, and monthly thereafter. Following external inspection of conjunctiva and adenexa, a slit lamp and dilated fundus examination was performed. Conjunctival biopsies were taken under local anesthesia and with separate sterile instruments for each animal.
Prior to infection, physical examinations and skin biopsies were performed and found to be normal. Routine parasitological fecal exams were performed, and animals with intestinal infestations were treated appropriately 4 weeks prior to infection with B. burgdorfen. Complete blood counts, serum chemistries, urinalysis, and physical examinations were performed for each animal prior to inoculation to determine baseline levels and then once weekly after inoculation. CSF was collected once monthly beginning at week 4 postinoculation (p.i.) for culture and cytology. Two tick-inoculated animals (J415 and J307) and one needle-inoculated animal (J748) were monitored with sequential CSF sampling. Animal K204 was monitored as a negative control. Other samples collected on a weekly or biweekly basis included blood for Western blotting and in vitro culture, urine for culture, and skin biopsies for culture and histopathology.
Source of ticks and tick infection procedure. All nymphal L dammini ticks were derived from a colony originating from Great Island, Mass. (12) . This colony has been maintained free of spirochetes for ca. five generations. Larval ticks were allowed to feed on B. burgdorferi (strain JD1)-infected Swiss outbred mice at 1 month p.i. Replete larvae were collected, held at 21°C and molted to nymphs. Nymphs were allowed to feed on monkeys at >2 months postmolting.
Monkey inoculation by ticks. The tick containment capsule consisted of a 60-ml polyethylene bottle that was cut off near the top, leaving the neck of the bottle attached to a flat base, and covered with a screw cap. A circular piece of fine mesh cloth extending about 1 in. (ca. 2.5 cm) beyond the base was glued to the capsule base with liquid plastic (Plasti Dip International, St. Paul, Minn.). A 1/4-in. (ca. 0.6-cm) hole was drilled in the center of the screw cap. A piece of fine mesh cloth was draped over the bottle neck, and the opening was covered by screwing the cap over it. The upper torso of each animal was closely shaven, rinsed with water, dried, and then sponged with Skin Prep (Smith & Nephew Medical, Massillon, Ohio), except in the area where the capsule would be placed. The cloth apron fastened to the capsule base and the skin area where the apron would eventually rest were coated with Skin Bond contact adhesive (Smith & Nephew Medical). The base of the capsule itself was coated with Super Glue, which is nonreactive with skin. The capsule base and cloth apron were adhered to the skin overlying the right scapula of each animal. The capsule was further fastened in place by wrapping a continuous 2-in. (ca. 5-cm)-wide strip of Hypafix adhesive dressing tape (Smith & Nephew Medical) three times around the entire upper torso, the capsule top being forced through a slit in the tape with each passage. The Hypafix tape then was covered in the same way with two layers of 2-in.-wide adhesive tape to help prevent the animal from pulling it loose from its body. Last, a nylon mesh vest that zippered in the back (Medical Arts, Los Angeles, Calif.) was fitted over the body of each animal. Mouth aspirators constructed from glass transfer pipets were used to separate the ticks into groups of 20 each and to transfer each group from the laboratory to the animal holding room. The pipet tip was inserted into a small hole drilled through the neck and screw cap, and then the ticks were blown into the capsule and the hole was sealed with hot glue. The tick capsule remained on the animal's body for 8 days, with the ticks put into the capsule on the third day.
B. burgdorferi infection rate of engorged ticks. All engorged ticks were assessed 3 weeks postattachment for residual spirochetes by the direct fluorescence microscopy method of Piesman et al. (32) .
In vitro cultivation of B. burgdorferi from stocks and from body fluids and tissue samples. Spirochetes were cultured in BSK II medium (2) at 34 to 35°C. Bacterial counts were made with a dark-field microscope on 5 to 10 calibrated standardized microscope fields (25 x objective), using 5 ,ul of culture medium; the mean number of bacteria per field was calculated and expressed as spirochetes per milliliter. The spirochetes were mass cultured in 500-ml spinner flasks or in 30-ml petri dishes either in gas-tight incubator boxes that had been continuously gassed with a mixture of 3% CO2, 5% 02, and the balance N2 or in a trigas incubator with the same gas concentrations. In cultures started with material from serial dilutions of spirochetes down to 0.7 cell per well, 7 of 10 wells became positive, confirming that single-cell inocula could be successfully expanded. For animal infection, cultured material was washed twice with RPMI 1640 medium to remove most of the macromolecular components of the BSK II medium. This was done to help avoid sensitizing the animals to these proteins. Viability of washed spirochetes was confirmed by in vitro culture. Samples of animal tissue, blood, urine, and CSF were placed in 24-well tissue culture plates with 1.0 ml of medium per well and kept for a maximum of 6 weeks in the same gas mixture as described above. For skin biopsy samples, one half of a 4-mm skin biopsy was minced and distributed into two wells. A volume of 50 ,ul of bodily fluid was dispensed into each of two wells. The wells were examined for spirochetes with an inverted positive-phase-contrast microscope at a magnification of x400, and presence of spirochetes was confirmed by darkfield microscopy. Part of the material from positive wells was used to confirm the Borrelia species by PCR, and the rest was stored in liquid nitrogen.
Species identification of cultured spirochetes by PCR. The PCR procedure of Goodman et al. (16) was used with some modifications. Oligonucleotide primers of 26 and 28 bp were synthesized and used to amplify a 231-bp fragment of B. burgdorfeni chromosomal DNA. Initial trials showed these primers to be specific for B. burgdorferi DNA and thus not able to hybridize to DNA from the closely related species Borrelia hennsii. This is in agreement with the results of Goodman et al. (16) , who also tested these primers for absence of hybridization to DNA from human cells, Eschenchia coli, Staphylococcus aureus, and Clostridium difficile.
Species identification by PCR thus afforded a specificity comparable to that of monoclonal antibodies, plus the possibility of completing species identification of all cultured (frozen) samples simultaneously in 1 day of work. Modifications of the original protocol included (i) employing one of the new generation of thermostable DNA polymerases, i.e., Vent polymerase (New England Biolabs, Beverly, Mass.) in lieu of Taq polymerase and (ii) use of a second amplification primer that is 7 bases downstream of the one originally described (1Sa). These primers were used to confirm the species of the spirochete present in medium from in vitrocultured blood and skin biopsy samples. A 10-j±l aliquot of the culture medium was placed in each reaction tube after all other components had been added. A positive control with pure B. burgdorferi DNA and a negative control consisting of all reaction components except added DNA were included. The mixtures were placed in a Perkin-Elmer Cetus DNA thermal cycler 480 and subjected to denaturation at 95°C for 5 min followed by a 9-min annealing period at 50°C and an extension time of 1 min at 72°C. The subsequent 39 cycles were at 94°C for 1 min, 50°C for 1 min, and 72°C for 1 min. During the final cycle, an extension time of 5 min at 72°C was used.
Histo-and immunohistochemistries. Each 8-mm skin biopsy was fixed in 10% buffered formalin, placed in tap water for 30 min, and then held in 80% ethyl alcohol until processed with a standard automated paraffin tissue processor. Tissues were then sectioned at 3 to 6 ,um and stained with hematoxylin-eosin. For immunological staining, an alkaline phosphatase-conjugated polyclonal antibody against organisms of the Borrelia genus and later a more specific anti-B. burgdorferi antibody (rendered species specific by adsorption with B. hermsii antigens), both produced in goats, were used as primary antibodies (Kirkegaard & Perry Laboratories, Gaithersburg, Md.). The sections were then stained by using alkaline phosphatase-linked anti-goat immunoglobulin antibodies andappropriatecolordevelopmentreagents (Kirkegaard & Perry Laboratories). Borrelia organisms stained red with a 1:400 dilution of the primary antibody. Positive control tissues included sectioned pellets of cultured organisms. Negative control tissues were from uninfected animals.
Western blotting. B. burgdorferi JD1 (fourth passage) was cultured in BSK II medium at 34°C up to a concentration of 108 cells per ml. Bacteria were pelleted and washed five times by centrifugation (8,000 x g, 20 min) with ice-cold phosphate-buffered saline (PBS), pH 7.2. After the last wash, the pellet was resuspended in an equal volume of sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) lysis buffer (0.05 M Tris-HCl [pH 7.5], 1% SDS, 10% [vol/vol] glycerol, 5% [vol/vol] 2-mercaptoethanol, 0.002% bromophenol blue) and heated at 100°C for 5 min. The lysate was centrifuged at 12,000 x g for 5 min, and the supernatant was collected, aliquoted in small volumes, and kept at -20°C until used. A volume of lysate containing 108 solubilized bacteria (or 25 p,g of protein measured by optical density at 280 nm, with an extinction coefficient of 1.4 ml.cm/mg) was dispensed per track of 1-mm-thick 10 to 20% acrylamide gradient minigels, electrophoresed, and transferred onto nitrocellulose essentially as described by Towbin et al. (41) . Nitrocellulose strips were blocked with 3% fat-free powdered milk in PBS containing 0.05% Tween 20 (PBS-T) for 2 h at room temperature. The strips were washed three or four times with PBS-T after each of the incubation periods described below. Blocked strips were incubated for 1 h with serum samples diluted 1:100 in PBS-T. Fig. 3G . The manufacturers instructions were followed verbatim.
Intrathecally produced anti-B. burgdorferi antibody in CSF. For determination of intrathecally produced anti-B. burgdorferi antibody in CSF, the DAKO Lyme Neuroborreliosis Kit (code no. K005; DAKO A/S, Filostrup, Denmark) was used according to the manufacturer's instructions. This is a sandwich-type enzyme immunoassay for the determination of intrathecally produced IgG and IgM antibodies to B. burgdorfeni flagellum protein.
In vitro assay for antibody-dependent complement-mediated lysis of B. burgdorferi. Normal monkey serum was used as a source of complement. Blood samples were collected from normal uninfected anesthetized rhesus macaques by femoral venipuncture and allowed to clot at room temperature for 30 min. Clotted blood was then kept at 4°C for 2 h. The serum was collected after centrifugation of the samples at 800 x g for 20 minutes and stored in small aliquots at -70°C. For the in vitro assay, cultured B. burgdorfeni organisms (JD1 strain, fourth passage) were centrifuged at 10,000 x g for 20 min, resuspended in BSK II medium, and counted. The complement-mediated killing assay was carried out in 96-well tissue culture plates. A total of 2.5 x 105 spirochetes in 25 ,l of BSK II medium were added to each well containing serially diluted 50-RI serum samples. The plates were incubated at 34°C for 20 min before the addition of 25 ,ul of normal rhesus monkey serum (source of complement). After 6 h of incubation at 34°C, the total numbers of dead (nonmotile) and live (motile) bacteria were determined by dark-field microscopy. The killing antibody endpoint titer was defined as one-half the value of the serum dilution at which the percentage of spirochetes killed was equal to that killed by rhesus monkey complement alone (10%). Equivalence between nonmotility and death was periodically controlled by reculturing the spirochetes over a 14-day period and verifying that the number of organisms recovered was proportional to the initial percentage that were motile. No organisms were recovered from wells initially rated as containing 100% nonmotile bacteria.
RESULTS
Infection status. B. burgdorferi could be recovered from all animals that were exposed to infected ticks or given the spirochete by injection, as revealed by in vitro culture of skin or blood samples (Table 1) and by immunostaining of skin sections ( Table 2 ). The spirochete species in cultured samples was confirmed to be B. burgdorfen by PCR. Thus, the expected species-specific 230-bp fragment of chromosomal DNA was amplified from all samples containing cultured spirochetes, but not in the absence of template.
Neither the route of infection nor the number of ticks that had fed on a given animal of group II affected the ability to detect the spirochete by in vitro culture (Table 1) . Thus, detection of B. burgdorfen in skin was possible 6 weeks p.i. in animals that received needle inoculations (J743 and K167) and in a monkey fed upon by only two ticks (J415). Results of in vitro cultures from blood samples were also independent of route of inoculation or number of infecting ticks, but overall, spirochetes were detectable for shorter time periods p.i. than in skin biopsies (Table 1) . No blood-borne organisms could be recovered from animal J797 (Table 1) .
Spirochetes were not recovered by in vitro culture from either urine or CSF during the first 8 weeks of infection; it should be noted, however, that CSF was sampled from only three animals (Table 1) . Overall, spirochetes were detected in blood by in vitro culture until week 6 p.i. (J743, K167, J415; Table 1 ), in skin biopsies taken from the periphery of the inoculation site until week 6 p.i. by in vitro culture (Table  1 ) and week 8 p.i. by immunostaining (Table 2) , and at week 10 p.i. in the conjunctiva of one animal selectively biopsied (see below).
Physical and microscopic examination findings. (i) Dermatologic. The gross and microscopic dermatologic evaluations are given in Table 2 . Erythema scored as El was the skin response associated with the feeding of the ticks. This response was present in animals exposed to the bite of both Borrelia-infected and uninfected ticks, but it persisted longer than 1 week p.i. only in infected animals. Erythema scored Immunophosphatase stain for B. buigdorferi: +, positive; -, negative.
as E2 was the response seen by or after week 1, and it appeared as a fine macular rash in the needle-inoculated animals (Fig. la) . The rash was more intense with defined borders in the form of a ring or circular patch of about 8 to 10 cm in diameter in tick-inoculated animals (Fig. lb) . E2 was seen in one animal of group I and, with various intensities and durations, in five of the six animals of group II but not in control monkeys. Erythema E3 differed from E2 only in that its location was distant from the site of inoculation. This type of secondary erythema was seen in animals J797 (tick inoculated) and K167 (needle inoculated). In the latter animal it was intense at 4 and 6 weeks p.i. (Table 2) . Microscopic evaluation consisted of hematoxylin-eosinand immunostained sections of skin biopsies. Dermatitis scored as Dl consisted of macrophage and lymphocyte infiltration into the superficial perivascular space immediately adjacent to the basement membrane of the epidermis. This was accompanied by a prominent eosinophil and an occasional basophil response. This response was observed in all animals exposed to the bite of a tick throughout a 6-week period p.i. The dermatitis termed D2 was characteristic of animals infected with B. burgdorferi. It consisted of lymphocytic infiltrates of the superficial perivascular areas as seen in Dl and, in addition, of the deep dermal adipose tissues (Fig. lc) and the perivascular spaces within muscle. The D2 response, which persisted through 8 weeks p.i. in three animals, was usually accompanied by the presence of Borrelia organisms, as demonstrated by immunostaining (Fig. lc) . The D3 dermatitis contained all the features of D2 but was more severe; cellular infiltrates, consisting primarily of mononuclear-type cells and lymphocytes, were often confluent in both the superficial and deep dermis. This degree of response was observed in two tick-inoculated animals (J797 and J415) at weeks 1 and 2 p.i.
Cutaneous nerve involvement, termed N ( within the nerve sheath. Dermal fibrosis, termed F in Table  2 , was prominent in two animals of group II (J677 and J797). It consisted of a reparative (anaplastic), sheet-like formation of fibrous connective tissue at the muscle-adipose tissue interface. A mild lymphocytic infiltration was seen in the connective tissue.
(ii) Ocular. All animals were examined prior to inoculation and found to be free of any observable ocular lesions. One needle-inoculated animal, K167, was noted to have mild conjunctival hyperemia when examined 1 week p.i. This persisted until 3 weeks p.i. and then disappeared. All other animals were within normal limits. During the 10th week p.i., two independent observers noted on different examination days that one tick-inoculated animal, J307, had bilateral conjunctivitis, greater in the right eye than in the left eye. At this time, the conjunctiva of K167 appeared normal bilaterally. Animals were examined by slit lamp biomicroscopy, and no evidence of uveitis was found. A conjunctival biopsy from the temporal limbus of both eyes of K167 (group I) and J307 (group II) was performed under topical anesthesia at 10 weeks p.i. The tick-inoculated animal, while manifesting obvious conjunctival injection, had histologic congestion but no inflammatory cell infiltration. No organisms were observed within the conjunctiva by immunohistochemistry. In contrast, needle-inoculated animal K167 showed no clinical signs of conjunctivitis but histologically demonstrated both epithelial hyperplasia with a mild lymphoplasmacytic infiltration of the submucosa and congestion of the vasculature (Fig. 2a) . Borrelia organisms were present, as assessed by immunohistochemistry (Fig. 2b) (ii) their ability to kill the spirochete in vitro, by antibodydependent complement-mediated lysis. The latter effector mechanism is known to kill the spirochete in vivo in rodent models (35) and in vitro with antibodies from infected animal models and humans (23, 26 (Fig. 3A) (Fig. 3D, tracks 10 (Fig. 3F) . By this time, however, the IgM response was much diminished (Fig.  3E) .
To illustrate the similarities between the specificities of the antibody responses of human and nonhuman primates, serum samples from all infected animals and one uninfected control were analyzed at 11 weeks p.i. with a commercially available Western blot-based diagnostic kit. All of the infected animals satisfied the two positive diagnostic criteria prescribed by the test's manufacturer, i.e., presence of "p41" and one or more "significant" bands in the "p18" to "p134" region, or presence of two or more "significant" bands in the "p18" to "p34" region (Fig. 3G) . Indeed, the similarity between the antigen recognition pattern of the human positive control serum sample supplied by the kit's manufacturer (chronic infection; Fig. 3G , track III) and the patterns of the infected rhesus macaques is remarkable. In addition, the antigen recognition patterns of three human serum samples obtained from patients in the early or early disseminated phases of Lyme disease are shown in tracks 13 of Fig. 3 . Two of these serum samples were obtained from patients at >9 months ( Fig. 3A and B ) and >3 months ( Fig.  3E and F) p.i. The third one (Fig. 3C and D) was obtained approximately 1 month p.i. All antigens recognized by rhesus monkey antibodies during the first 6 weeks of infection appeared to be recognized also by the human serum antibodies. Although the full spectrum of antibody specificities observed in long-term chronically infected humans was not elicited in rhesus monkeys during the 13-week investigation period, the trend towards increasing complexity in the antibody response indicates that at some point the diversity observed in humans may be observed also in our model. Fig. 4 . Titers were the same at week 3 p.i., when the IgM response is still high but the IgG antibody response is less developed (not shown).
DISCUSSION A useful animal model for an infectious disease of humans should accurately mimic the microbiological, clinical, immunological, and pathological aspects of the infection. Moreover, the animal's immune system should be amenable to detailed experimental analysis. To date it has not been possible to reproduce the protean nature of Lyme disease in experimental animals. The models reported on in the literature, specifically, rats and mice (3, 4, 34) , hamsters (13, 19, 21, 36) , dogs (28) , and rabbits (6) , show a limited number of disease signs, manifested in most cases only in animals with an impaired or undeveloped immune system. In contrast, rhesus macaques displayed not only several of the clinical and pathological signs of human Lyme disease but also important attributes of the human antibody response to infection.
EM, the most often observed sign of infection in humans (60 to 80%) (39), was noted clinically in six of nine infected rhesus monkeys. Microscopically, the tissue patterns observed in skin biopsies were similar to those seen in human Lyme borreliosis, particularly the deep and superficial perivascular lymphocytic infiltrations. These are so characteristic of human EM that they are considered diagnostic by some investigators (5) . Dermal fibrosis has been described as a chronic manifestation of human Lyme disease (15, 24) . The appearance of dermal fibrosis at 8 weeks p.i. may signal a change in the host response from one characteristic of early Lyme disease, i.e., acute dermatitis, to late, chronic dermatitis.
Both EM and conjunctivitis (detected histochemically) were documented concomitantly with presence of the spirochete in skin and conjunctival biopsies. Conjunctivitis was observed in two animals that were biopsied. One of the two monkeys had red eyes clinically. The second monkey had no redness clinically, but conjunctivitis and B. burgdorfen were detectable histologically. This result indicates that ocular manifestations of Lyme disease may occur in the rhesus monkey more frequently than we have noticed and, by analogy, may be underdiagnosed in humans.
The reticuloendothelial changes noted in three animals, i.e., splenomegaly, disappeared within 2 weeks of their onset. Splenomegaly occurs during the early disseminated phase of human Lyme disease and is characteristically The sinus bradycardia noted on two occasions in one animal is reminiscent of the varying degrees of heart block with secondary bradycardia that have been observed during the early disseminated phase of Lyme disease in humans (39) . However, our finding is probably normal, for although conduction abnormalities may have been present in this animal, lengthening of the P-R wave interval was not observed on electrocardiogram.
Neurologic signs such as paresis of oculomotor and facial nerves were not observed. The high WBC count found in the CSF of two of the three animals whose CSF was analyzed is abnormal. Species other than rhesus macaques may show 4 x 103 to 1 x 104 WBC per ml in the absence of infection (42) by in vitro culture. Second, although antibodies to B. burgdorfeni antigens were present in CSF samples, the antigens recognized did not differ from those bound by serum antibodies collected concomitantly with the CSF. Furthermore, intrathecal antibody production was not observed. While human neuroborreliosis is not always reliably confirmed by in vitro culture of CSF samples (22) , intrathecal antibody production is reputedly the most significant marker for its diagnosis (29) . Therefore, at this point we cannot correlate the CSF cellular infiltrates with the B. burgdorfen infection.
It should be noted, however, that the number of animals with pleocytosis in CSF could be higher than recorded, since only three of nine infected animals were sampled for CSF. Finally, the lymphoplasmacytic infiltration of cutaneous nerves and sheath vacuolation we observed could indicate a port of entry for B. burgdorfien into the peripheral nervous system.
Clinical signs of arthritis were not observed in any of the infected animals of group I or II. Nonetheless, we have preliminary evidence that arthritis may indeed occur in the rhesus monkey as a result of B. burgdorferi infection. In a separate group of five B. burgdorferi-infected rhesus macaques currently under investigation, one animal developed swelling in multiple joints 14 days p.i., B. burgdorferi was recovered by in vitro culture of synovial fluid from this animal (our unpublished data). We will continue to monitor animals of groups I and II, in search of chronic signs of arthritis.
Routine clinical laboratory studies of rhesus monkeys showed no abnormal results during the 13-week-period studied. Results of similar studies in humans with Lyme disease are also rarely abnormal (40) .
Western blot analysis of serum samples showed that the number of antigens recognized by rhesus monkey antibody increased steadily as a function of time after infection. Such a pattern of increasing complexity in the antibody response is characteristic of Lyme disease in humans (18, 30) . Indeed, it has been suggested that its time dependence could be used as an aid to establish duration of infection (30) . This contention seems to be borne out by the data from our model, where we can state with certainty the time when infection began.
In most animals the relative molecular weights of the antigens recognized were the same as those described for humans (18, 27, 30) , at least as far as it is possible to compare Mrs measured in different SDS-PAGE systems. In a recent study (27) , antibodies to antigens of Mrs of (103) 94, 83, 75, 66, 60, 55, 46, 41, 39, 34, 31, 29, 22 , and 17 were regularly detected in a sample of 186 serum specimens from individuals with clinically diagnosed Lyme borreliosis. The Western blot obtained with the commercially available diagnostic kit from Immunetics clearly illustrates the similarity between the antigen recognition patterns of humans and monkeys (Fig. 3G) . The most significant marker in terms of frequency of recognition and specificity was the 39,000Mr antigen, which was recognized by all of the infected and none of the uninfected monkeys by week 6 p.i. (Fig. 3F) .
Our in vitro analysis of the main borreliacidal effector mechanism identified to date, antibody-dependent complement-mediated killing, showed that despite the early appearance of diverse antibody specificities to B. burgdorferi in rhesus macaques, the borreliacidal titer of these antibodies in needle-inoculated animals was low (1:320) at 3 to 5 weeks p.i. compared with that in hamsters by 3 weeks p.i. determined by using a similar in vitro assay (titers of 1:1,280) (26) . Tick-inoculated animals developed a titer of borreliacidal antibodies (1:80) lower than that of needle-inoculated monkeys and lower than that observed in humans with late Lyme disease (about 1:680) (7). Nonetheless, this killing mechanism is available and may be functional in the rhesus monkey. To elicit its full host-protective potential, the bactericidal antibody titer may need boosting by means of an appropriate vaccination protocol administered before B. The differences in the borreliacidal antibody titers observed in animals of groups I and II could be due, at least in part, to the fact that serum samples from animals in group I contained easily detectable antibodies to OspA, an outer surface protein, whereas those from animals of group II did not (Fig. 3) . Such a difference between the detectabilities of an anti-OspA antibody response in animals infected via the natural route and by injection has already been observed in dogs and in hamsters. Naturally infected animals show no antibody response to OspA detectable by Western blot or ELISA, whereas needle-inoculated animals do produce this antibody in detectable amounts (17, 33) . Indeed, in human infections with B. burgdorfen, anti-OspA antibodies have been found early after infection only in the form of immune complexes (37) . Antibodies detectable by standard diagnostic procedures appear very late in the infection, if at all (11) .
Diagnosis of Lyme disease, still an imprecise endeavor (38) , will benefit from the availability of the rhesus monkey model. Immunological reagents such as antibodies to human immunoglobulin isotypes cross-react better with their rhesus monkey counterparts than with those of most other nonhuman primate species used in the laboratory (our unpublished data). Thus, recombinant antigens may now be tested for antibody detection longitudinally, with the same reagents used for humans but in a study population positively known to be infected with B phases of the infection. The time when late (chronic) signs begin to be expressed, which would be around 1 year after infection in humans (39) , has not been reached in our study.
